— Know what they know.
Not Investment Advice
Also trades as: MYND.CN (CNQ) · $vol 0M

MYNDF OTC

MYND Life Sciences Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: -41.3% 3Y: -55.0%
$0.01
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Strong Sell · Power 39 · $657843 mcap · 81M float · 0.0082% daily turnover · Short 100% of daily vol

Cash Flow Trends

Operating Cash Flow
-$198K +89.1% ▲
Capital Expenditures
$0 +0.0% ▲
Free Cash Flow
-$198K +89.1% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$155 +100.0% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2019FY2020FY2021FY2022FY2023
— Operating Activities —
Net Income-$3K-$56K-$4M-$4M-$2M
Depreciation & Amort.$0$0$86K$60K$21K
Stock-Based Comp.$0$0$1M$103K$23K
Change in Working Capital$0$0-$213K$1M$2M
Other Non-Cash Items$2K$54K$517K$496K-$473K
Operating Cash Flow-$708-$3K-$3M-$2M-$198K
— Investing Activities —
Capital Expenditures$0$0-$149K$0$0
Acquisitions (Net)$0$0$2M$0$223K
Investment Purchases$0$0$0$0$0
Investment Sales$0$0$0$0$0
Other Investing$0$0$0-$80K-$25K
Investing Cash Flow$0$0$2M-$80K$198K
— Financing Activities —
Net Debt Issuance$0$0$3M$0$0
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$708$3K$0$0$0
Financing Cash Flow$708$3K$3M$0$0
Net Change in Cash$0$0$2M-$2M-$155
Cash End of Period$0$0$2M$412$257
Free Cash Flow-$708-$3K-$3M-$2M-$198K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms